Coya Therapeutics (COYA) Expected to Announce Quarterly Earnings on Tuesday

Coya Therapeutics (NASDAQ:COYA - Get Free Report) is projected to issue its quarterly earnings data before the market opens on Tuesday, March 18th. Analysts expect the company to announce earnings of ($0.32) per share for the quarter.

Coya Therapeutics Stock Performance

NASDAQ:COYA traded up $0.01 during mid-day trading on Friday, hitting $6.49. The stock had a trading volume of 113,745 shares, compared to its average volume of 76,397. Coya Therapeutics has a twelve month low of $4.75 and a twelve month high of $10.69. The stock has a market cap of $108.43 million, a price-to-earnings ratio of -9.98 and a beta of 0.31. The company's 50 day simple moving average is $6.27 and its 200 day simple moving average is $6.46.

Analysts Set New Price Targets

COYA has been the subject of several recent analyst reports. D. Boral Capital reiterated a "buy" rating and issued a $15.00 target price on shares of Coya Therapeutics in a research note on Monday. Chardan Capital restated a "buy" rating and set a $14.00 price objective on shares of Coya Therapeutics in a research report on Thursday, February 6th.

Coya Therapeutics Company Profile

Coya Therapeutics, Inc, a clinical-stage biotechnology company, engages in the development of proprietary medicinal products to modulate the function of regulatory T cells (Tregs). The company's product candidate pipeline is based on therapeutic modalities, such as Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy.